Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeMethodology and Results of the study
Posted by sarman_singh on 09 Mar 2013 at 07:53 GMT
It is surprising that even if all 611 patients were MDR suspects how come that all 483 isolates were bacteriologically MDR as well and no pan-sensitive? In real life such results are never observed. We have been doing similar studies and in all clinically suspected MDR patients not more than 75% are actually MDR strains, and several of these 75% will be resistant to one or more drug not fulfilling the criteria MDR. Hence we expect that author will provide information that how many were sensitive isolates or in other words how many total isolations were made from 611 patients.
Thanks
Prof. Sarman Singh
RE: Methodology and Results of the study
drurvashi replied to sarman_singh on 14 Mar 2013 at 01:57 GMT
The study was designed with the specific objective to look for XDR-TB among MDR-TB patients and study the demographic characters. Special effort was made to enroll MDR-TB patients from amongst patients with high clinical suspicion. We identified 483 of 611 patients enrolled as MDR-TB (79%).
Drug susceptibility testing was performed only for Rifampicin and Isoniazid in order to identify MDR-TB isolates. Strains that were sensitive to either RIF/INH or both drugs were excluded from further workup (n=128).